AP2000001787A0 - Use of thiazolidinediones for the treatment of hyperglycaemia. - Google Patents

Use of thiazolidinediones for the treatment of hyperglycaemia.

Info

Publication number
AP2000001787A0
AP2000001787A0 APAP/P/2000/001787A AP2000001787A AP2000001787A0 AP 2000001787 A0 AP2000001787 A0 AP 2000001787A0 AP 2000001787 A AP2000001787 A AP 2000001787A AP 2000001787 A0 AP2000001787 A0 AP 2000001787A0
Authority
AP
ARIPO
Prior art keywords
hyperglycaemia
treatment
thiazolidinediones
efective
mammal
Prior art date
Application number
APAP/P/2000/001787A
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AP2000001787A0 publication Critical patent/AP2000001787A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A method for the treatment of hyperglycaemia wherein plasma glucose levels are in the range of elevated normal to less than or equal to 126mg/dl, which method comprises administering an efective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser, to a mammal in need thereof.
APAP/P/2000/001787A 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia. AP2000001787A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment
PCT/GB1998/003064 WO1999018943A1 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia

Publications (1)

Publication Number Publication Date
AP2000001787A0 true AP2000001787A0 (en) 2000-06-30

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2000/001787A AP2000001787A0 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia.

Country Status (24)

Country Link
EP (1) EP1023056A1 (en)
JP (1) JP2001519382A (en)
KR (1) KR20010024481A (en)
CN (1) CN1281359A (en)
AP (1) AP2000001787A0 (en)
AU (1) AU9547098A (en)
BG (1) BG104404A (en)
BR (1) BR9815219A (en)
CA (1) CA2306086A1 (en)
CZ (1) CZ20001297A3 (en)
EA (1) EA002659B1 (en)
GB (1) GB9721693D0 (en)
HR (1) HRP20000255A2 (en)
HU (1) HUP0003922A3 (en)
ID (1) ID24521A (en)
IL (1) IL135513A0 (en)
NO (1) NO20001898L (en)
NZ (1) NZ503862A (en)
OA (1) OA11683A (en)
PL (1) PL339813A1 (en)
SK (1) SK5312000A3 (en)
TR (1) TR200000958T2 (en)
WO (1) WO1999018943A1 (en)
YU (1) YU28800A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (en) * 1987-09-04 1999-12-15 Beecham Group Plc SUBSTITUTED THIAZOLIDINEDIONE DERIVATIVES
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
HRP20000255A2 (en) 2001-02-28
TR200000958T2 (en) 2000-08-21
WO1999018943A1 (en) 1999-04-22
ID24521A (en) 2000-07-20
CN1281359A (en) 2001-01-24
BR9815219A (en) 2001-01-02
CZ20001297A3 (en) 2001-08-15
EA200000419A1 (en) 2000-10-30
NZ503862A (en) 2003-01-31
PL339813A1 (en) 2001-01-02
SK5312000A3 (en) 2000-09-12
EA002659B1 (en) 2002-08-29
YU28800A (en) 2003-02-28
NO20001898D0 (en) 2000-04-12
OA11683A (en) 2005-01-12
NO20001898L (en) 2000-06-09
EP1023056A1 (en) 2000-08-02
CA2306086A1 (en) 1999-04-22
KR20010024481A (en) 2001-03-26
GB9721693D0 (en) 1997-12-10
IL135513A0 (en) 2001-05-20
BG104404A (en) 2000-12-29
HUP0003922A3 (en) 2001-12-28
HUP0003922A2 (en) 2001-10-28
JP2001519382A (en) 2001-10-23
AU9547098A (en) 1999-05-03

Similar Documents

Publication Publication Date Title
EP1787646A3 (en) Novel method of treatment
MXPA05007470A (en) Long acting insulin for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes.
WO2000007575A3 (en) Methods and compositions for increasing insulin sensitivity
SG127714A1 (en) Method of treating metabolic disorders, especiallydiabetes, or a disease or condition associated wi th diabetes
MXPA03003870A (en) Combination therapy comprising anti-diabetic and anticonvulsant agents.
AP2001002291A0 (en) Novel method of treatment.
WO2003082260A3 (en) Tuberculosis treatment using pleuromutilin derivatives
MY155219A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide
HK1047707A1 (en) Use of (+)-tramadol, o-demethyltramadol or (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol or (+)-o-desmethyl-n-mono-desmethyl-tramadol for treating urinary incontinence
HK1060280A1 (en) Reducing side effects of chemotherapy in cancer patients
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
BG104059A (en) Diabetes treatment with rosiglytazone and insulin
AU1720697A (en) Nutrient composition for exercise
AP9901720A0 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitors.
MY125855A (en) Treatment of diabetes with a thiazolidinedione and sulphonylurea
MY138246A (en) Treatment of diabetes with thiazolidione and sulphonylurea.
AP2000001735A0 (en) Treatment of diabetes with thiazolidinedione insulin secretagogue and alpha glucocidase inhibitor.
AP2000001787A0 (en) Use of thiazolidinediones for the treatment of hyperglycaemia.
CA2234936A1 (en) Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
TR200101336T2 (en) Combinations with a beta-agonist and another antidiabetic agent
YU28700A (en) Use of thiazolidinediones for the treatment of hyperglycaemia
WO1999064065A3 (en) Tumour therapy and imaging
MX9701606A (en) Combination therapy to prevent bone loss- progesterone and strogen.
AU4937499A (en) Use of succinic acid or salts thereof and method of treating insulin resistance
WO2001047509A3 (en) Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions